Claims for Patent: 4,340,581

Summary for Patent: 4,340,581

Title:	Process for the immunological determination of basal membrane material and new basal membrane suitable therefor
Abstract:	This invention relates to a process for the immunological determination of asal membrane material in body fluids and provides new basal membrane fragments suitable for such determination, and a process for their preparation.
Inventor(s):	Timpl; Rupert (Krailing, DE)
Assignee:	Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. (Gottingen, DE)
Application Number:	06/154,735
Patent Claims:	1. Process for the immunological determination of basal membrane material in body fluids, which process comprises incubating a tagged basal membrane antigen selected from tagged laminin, tagged laminin fragment P1 and tagged basal membrane fragment 7S collagen, with a first antibody specific to said antigen in the presence of the body fluid sample to be tested, whereby antigens in the body fluid sample will compete with said tagged antigen for said antibody, separating the antigen-antibody-complex formed, and determining the quantity of tagged antigen contained in the complex or in the separated liquid as a measure of the basal membrane material contained in said body fluid. 2. Process as claimed in claim 1 wherein the antigen is tagged radioactively. 3. Process as claimed in claim 1 wherein the antigen is tagged enzymatically. 4. Process as claimed in claim 1 wherein the antigen is fluorescence tagged. 5. Process as claimed in claim 1 wherein the first antibody is from an antiserum raised in a suitable animal species and the step of separating the antigen-antibody complex includes adding, a second antibody which second antibody is against the immunoglobulin G of the animal species used for the preparation of the anti-serum. 6. Process as claimed in claim 1 wherein the antibody or anti-serum is bound to a solid carrier. 7. Process as claimed in claim 1 wherein said first antibody is in the form of rabbit anti-serum or antibody. 8. Laminin suitable for the immunological determination of basal membrane material in body fluids, comprising a glyco protein of 12 to 15% by weight carbohydrate content and a molecular weight of 800 to 1,000 k, consisting of two disulfide-linked polypeptide chains of a molecular weight of about 220 to 440 k. 9. Laminin fragment P1 suitable for the immunological determination of basal membrane material in body fluids, having a molecular weight of 200 to 300 k, a cysteine content of 12 to 14% Mol, and a high degree of affinity for lectin and stability toward collagenase. 10. Basal membrane peptide 7S collagen suitable for the immunological determination of basal membrane material in body fluids, having a molecular weight of 200 to 300 k, a cysteine content of 2 to 5% Mol, and axial ratio of the order of 1:20, a stable triple helix with a melting point in the range of 60.degree. to 70.degree. C., and resistent to collagenase. 11. Process for the preparation of the of claim 8 comprising extracting a tissue material containing a basal membrane in the presence of protease inhibitors, first with high salt concentrations, then with 0.4 to 0.6 M NaCl, separating the laminin by salt precipitation from the extract using 0.4 to 0.6 M NaCl, and optionally dissolving the precipitate and subjecting same to chromatography. 12. Process for the preparation of laminin fragment P1 comprising extracting tissue containing basal membrane with a concentrate of salt solution of 0.4 to 0.6 M NaCl, dialyzing the solution obtained containing the fraction precipitated between 2 M and 4 M NaCl from the dialyzed solution, and subjecting same to the chromatography with a weakly basic cation-exchanger and with lectin. 13. Process for the preparation of laminin as claimed in claim 8 comprising incubating laminin with protease, dialyzing the solution obtained containing the fraction precipitated between 2 M and 4 M NaCl from the dialyzed solution, and subjecting same to chromatography with a weakly basic cation-exchanger and with lectin. 14. Process for the preparation of basal membrane peptide 7S collagen suitable for the immunological determination of basal membrane material, which process comprises extracting tissue containing basal membrane in the presence of protease inhibitors with concentrated salt solutions and then with 0.4 to 0.6 M NaCl, incubating same with a protease, dialyzing the resulting solution, precipitating the 7S collagen from the dialyzed solution with 2 M NaCl, dissolving the precipitate, incubating same with collagenase, and the dialyzing and subjecting the incubate to chromatography. 15. Process as claimed in claim 11 wherein the tissue material containing a basal membrane is human placenta or mouse EHS-sarcoma. 16. Process as claimed in claim 12 wherein the tissue material containing a basal membrane is human placenta or mouse EHS-sarcoma. 17. Process as claimed in claim 13 wherein the tissue material containing a basal membrane is human placenta or mouse EHS-sarcoma. 18. Process as claimed in claim 14 wherein the tissue material containing a basal membrane is human placenta or mouse EHS-sarcoma.

Details for Patent 4,340,581

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		1999-07-20
Octapharma Pharmazeutika Produktionsges.m.b.h.	CUTAQUIG	immune globulin subcutaneous (human)-hipp	Solution	125668	12/12/2018		1999-07-20